Background and aims Leukocyte telomere length (LTL) is a novel marker of cardiovascular (CV) risk. The aim of the study was to investigate the major determinants of LTL in a healthy young population at very low CV risk. Methods and results LTL was determined in 82 healthy subjects (49M/33F; age37 ± 9yrs), normotensive and not taking any medication with different family history of cardiovascular disease (CVD) (24yes/58no). Fasting blood samples were drawn in all subjects for the determination of lipid profile, high sensitive C-reactive protein, uric acid, Plasminogen Activator Inhibitor-1 (PAI-1), LTL and Endothelial Progenitor Cell (EPC) number. LTL was assessed with a specific real-time PCR reaction in leukocyte DNA samples. LTL resulted inversely correlated with family history of CVD (t = 2.70; p = 0.009), age (r = −0.238; p = 0.032), waist circumference (r = −0.256; p = 0.02), triglycerides (r = −0.218; p = 0.049), PAI-1 (r = −0.288; p = 0.009) and directly correlated with HDL-cholesterol (r = 0.316; p = 0.004) and EPC number (r = 0.358; p = 0.002). At a multivariate analysis, family history of CVD (p = 0.013), EPC count (p = 0.003), and HDL-cholesterol (p = 0.017) were independently associated with LTL (r = 0.62). Conclusion LTL is independently associated to CV risk factors also in healthy young adults.
Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure / E., Vizzardi; A., D'Aloia; R., Giubbini; T., Bordonali; S., Bugatti; N., Pezzali; A., Romeo; DEI CAS, Alessandra; M., Metra; L. DEI C. A., S.. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 106(9):(2010), pp. 1292-1296. [10.1016/j.amjcard.2010.06.052]
Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure
DEI CAS, Alessandra;
2010-01-01
Abstract
Background and aims Leukocyte telomere length (LTL) is a novel marker of cardiovascular (CV) risk. The aim of the study was to investigate the major determinants of LTL in a healthy young population at very low CV risk. Methods and results LTL was determined in 82 healthy subjects (49M/33F; age37 ± 9yrs), normotensive and not taking any medication with different family history of cardiovascular disease (CVD) (24yes/58no). Fasting blood samples were drawn in all subjects for the determination of lipid profile, high sensitive C-reactive protein, uric acid, Plasminogen Activator Inhibitor-1 (PAI-1), LTL and Endothelial Progenitor Cell (EPC) number. LTL was assessed with a specific real-time PCR reaction in leukocyte DNA samples. LTL resulted inversely correlated with family history of CVD (t = 2.70; p = 0.009), age (r = −0.238; p = 0.032), waist circumference (r = −0.256; p = 0.02), triglycerides (r = −0.218; p = 0.049), PAI-1 (r = −0.288; p = 0.009) and directly correlated with HDL-cholesterol (r = 0.316; p = 0.004) and EPC number (r = 0.358; p = 0.002). At a multivariate analysis, family history of CVD (p = 0.013), EPC count (p = 0.003), and HDL-cholesterol (p = 0.017) were independently associated with LTL (r = 0.62). Conclusion LTL is independently associated to CV risk factors also in healthy young adults.File | Dimensione | Formato | |
---|---|---|---|
science.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
186.3 kB
Formato
Adobe PDF
|
186.3 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.